Dri CE
Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada.
ArticleKetamine
Cognitive effects of ketamine and esketamine treatment for major depressive and bipolar disorder: a systematic review.
ArticleMDMA
The Serotonin 2B (5-HT2B) Receptor: A Narrative Review of Preclinical and Clinical Evidence on the Safety Considerations and Therapeutic Potential for the Treatment of Depression.
ArticleKetamine
Effect of ketamine on reward processing in depressive disorders: a systematic review of neuroimaging studies.
ArticleKetamine
Are the current safety measures for the treatment of depression with esketamine sufficient?
ArticleKetamine
The use of repetitive transcranial magnetic stimulation (rTMS), electroconvulsive therapy (ECT), ketamine, and esketamine in reducing suicidality in major depressive disorder: A comprehensive narrative review.
ArticlePsilocybin
Cardiac Consequences Associated with Psychedelic Use: A Systematic Review of Lysergic Acid Diethylamide, 3,4-Methylenedioxymethamphetamine, and 5-Hydroxytryptamine 2B-Mediated Valvular Heart Disease.
ArticleKetamine
Is the antidepressant efficacy of ketamine and esketamine mediated via opioid mechanisms?
ArticleKetamine
Effects of Intravenous Ketamine on Posttraumatic Stress Disorder (PTSD): A Systematic Review.
ArticleKetamine
The effects of ketamine and esketamine on functional outcomes in major depressive disorder and treatment-resistant depression: A systematic review.
ArticleKetamine
A Systematic Review of the Effects of N-Methyl-D-Aspartate Receptor Antagonists on Pancreatic Islets.
ArticleKetamine
Ketamine and Esketamine for Late-Life Depression: A Systematic Review of Efficacy, Safety, and Tolerability.
ArticleKetamine